(English) Inovio Pharmaceuticals, Inc.
Join Class Action »
(English) SHAREHOLDER ALERT: Zhang Investor Law Announces a Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO
New York, N.Y., March 14, 2020. Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between February 14, 2020 and March 9, 2020, inclusive (the “Class Period”).
To join the INO class action, go to http://zhanginvestorlaw.com/cases/inovio-pharmaceuticals-inc/ call Sophie Zhang, Esq. toll-free at 800-991-3756 or email firstname.lastname@example.org for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU NEED NOT BE LEAD PLAINTIFF IN ORDER TO SECURE A RECOVERY.
According to the lawsuit, throughout the Class Period made false and/or misleading statements about the company’s development of a purported vaccine for the novel coronavirus, artificially inflating the company’s share price and resulting in significant investor losses.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 11, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://zhanginvestorlaw.com/cases/inovio-pharmaceuticals-inc/ or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. of Zhang Investor Law toll free at 800-991-3756 or via e-mail at email@example.com.
Zhang Investor Law represents investors worldwide.